Avista Public Acquisition Corp. II

Status: Deal Closed
U=S+W/3 W=S@11.5
IPO Proceeds, $M $230.00M
IPO Date Aug 10, 2021
CEO David Burgstahler
Left Lead Credit Suisse
IPO Cash in Trust 102.5%
SPAC Tenor 18 months
IPO Sector Healthcare
IPO Geography Global
Target Company OmniAb
Deal Announced Mar 23, 2022
Deal Size, $M $884.00M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Oct 24, 2022
Amendment Vote TBD
Closing Date Nov 1, 2022
Formerly AHPA OABI OABIW

Sign up for Free Trial

No credit card required

Sign in for more on Avista Public Acquisition Corp. II:

  • Structure and cap table
  • 11 directors & officers
  • 27 filings and events
  • 1 underwriters
  • 9 deal advisors
  • 1 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Thompson Dean 63 Executive Chairman and Director
David Burgstahler 52 President, Chief Executive Officer and Director
Sriram Venkataraman 49 Executive Vice President
Robert Girardi 39 Executive Vice President
Amanda Heravi 46 Investor Relations Officer
John Cafasso 48 Chief Financial Officer
Benjamin Silbert 50 General Counsel
William E. Klitgaard 68 Director
Lâle White 66 Director
Wendel Barr 59 Director
Charles Harwood Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Credit Suisse BR 20,000,000 units
20,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 27 filings.

Shareholders

Sign in to view shareholders 13F filing data.